Companies › Semiconductors

Synopsys SNPS

SemiconductorsMarket cap $85B7 connections

Synopsys makes EDA (electronic design automation) software - the CAD tools that engineers use to design chips. Without Synopsys tools, no one could design a modern CPU or GPU. Its Fusion Compiler and VCS simulation are industry standards. Its acquisition of Ansys (pending) would add simulation software, creating the most comprehensive engineering simulation platform.

Explore Synopsys on the interactive map Relationship timeline Find a path to another company

Customers 6

Companies Synopsys sells to

  • AppleTechnology · $3.0TEDA for A-series chip design
  • NVIDIASemiconductors · $2.2TChip design EDA tools
  • TSMCSemiconductors · $900BChip design for TSMC process
  • AMDSemiconductors · $250BCPU verification tools
  • QualcommSemiconductors · $185BRTL design tools
  • IntelSemiconductors · $180BDesign verification tools

Partners 1

Strategic partnerships, joint products and alliances

Key relationships in depth

Synopsys & Apple

Synopsys provides the Electronic Design Automation (EDA) software that Apple's silicon team uses to design every A-series and M-series chip. EDA tools are the CAD software of semiconductors; without them, managing the complexity of a chip with 16 billion-plus transistors is not possible. Apple Silicon employs approximately 12,000 engineers whose core design workflow depends on Synopsys and Cadence tools.

Why it matters: Apple's vertical integration strategy of designing custom chips rather than buying off-the-shelf silicon from Arm or Qualcomm is only viable because EDA tools have advanced to manage extraordinary design complexity. Synopsys and Cadence hold a near-duopoly on EDA, making them critical infrastructure for every major semiconductor designer including Apple, NVIDIA, and AMD.

Other Semiconductors companies

Embed this on your site

Show Synopsys's network in an article or report - it updates as our data does.

Preview

Relationships are compiled by VexMap from company filings, announcements and reporting, and last reviewed September 2026. Spotted something wrong? Tell us. Not investment advice.